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There is an abundance of lit.erature dealing with 
specific mediator~ or classes of mediators and the 
evidence supporting their participation in inflam-
mation . The same problem can. however. be ap -
proached differently by start ing with a clinically 
defined inflammatory skin disorder. t he pha r-
macologic mediators of which are to be sought. The 
question to be asked is this: here we ha\'e a 
clinically defined inflammatory skin disea e-how 
do we go about identifying the pharmacologic 
mediators involved in its pathogenesis? The prob-
lem of how to recover. analyze, and characterize 
mediators from inflamed tissues is very rarely 
considered , 
Two types of experiment can be carried ou t : 
1. Direct experiments . These involve firsily the 
recovery of inflammatory exudate and then testing 
it for pharmacologic activity whi ch. if present. is 
analyzed by physical. pharmacologic. and bio-
chemical methods. The difficulty with this type of 
experimenr i that it can reveal only the presence 
of specific activit.y; it does not enable conclusions 
to be dra wn about the role of the specific acti\'it~·. 
However, wi th that caveat. very useful information 
can be gleaned from direct experiments. 
2. Indirect experiments. In this method other 
drugs with inhibitory activity possessing some 
degree of specifici ty are used as tools to reveal the 
presence of mediators. Examples include use of 
antihistamines to reveal the presence of histamine 
acti"ity or atropine to revea l acetyl cholin e. and in-
domethacin to reveal prostagland in synthetase ac-
ti,·ity . lnhi bit ion can also be produced by d rugs 
which specifically deplete skin of an agen t. An ex-
ample of this is the histamine libera tor. compound 
48/80. Gnfortunately. speci fi city is rarely absolute. 
Many antihistamines a lso possess at ropine-like ac-
tiv iw. and indomethacin inh ibits inflammation by 
inhibiting leukocyte migration independent I, · of its 
action on prostaglandin synthetase. However, 
indirect methods do have one big advantage: a 
positive result suggests not only the presence of the 
pharmacologic agent, but also that it is behaving 
as a mediator. Indirect methods are the refore 
useful , especially when used in conjunction with 
direct experiments. 
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There are a number of details of direct experi-
ments that must be considered. 
Recovery . The first step is to collect inflamma-
tory exudate for analysis. The a im should he to 
obtain undiluted exudate by a means that avoids 
artificial generation, release. or degradation of 
mediators. In man it is probably impossible to 
achieve these aims completely. Previou Iy we have 
used a skin perfusion techn ique [II bu t here the 
difficulty is that ooe is greatly d iluting the mate-
rial one intends to study. The method is only 
semiquantitative because the concentration in the 
perfusate depends on facto rs difficult to control , 
i ncl uding tissue diffusion and uptake by the blood 
and lymphatic circulation . Nevertheless, we 
obtained some valuable results with this method. 
including t he recovery and identification of prosta-
glandin activity in allergic contact dermatitis. We 
are now using a more sat isfactory method which 
im'ol ves raising a suction bulla on the inflamed 
skin [2 1. Provided the skin temperature and suc-
tion pressure is standardized. it is possible to raise 
a series of suction bullae. the fluid from which in 
normal skin conta ins l ittle or no pharmacologic 
activity but which in inflamed skin conta ins spe-
cific activity. An alternate method we are currently 
exploring is the recovery of lymph dra ining the 
upper and lower limb. The technique is si mply to 
inject dye into t he interdigita l cleft as for lymphan -
giography. The main lym phatic trunks can then 
readily be identified more proximally in the limb 
and exposed. Lymph can then be recovered by 
insertion of a fine cannula. The analy is of lymph 
draining inflamed limbs should yie ld mu ch more 
satisfactory results than study of venous blood . 
because of the proneness of the latter to liberate 
massive amounts of pharmacologic activity due to 
coagulation and platelet clumping. 
Analysis. It is perfectly feasible to apply specific 
tests fo r individual recognized mediators. How· 
ever, t here is the risk of missing hitherto unknown 
mediator activity. It seems more sa tisfactory to 
screen the exudat.e for pharmacologic activity 
which is then systemat ically broken down and 
analyzed into its individual components. After 
recognized agents have been identified and ex-
cluded. any residual " unrecognizable " activ ity can 
be characterized . 
Ideally the screening procedure should test for 
pro- inflammatory activity in some form . However, 
methods measuring vasoactivity are almost entire· 
Iy in vivo methods which lack pharmacologic 
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specificity and make subsequent analy is by 
antagonists difficult, since they have to be given to 
the whole animal. 
A better method is to test the exudate for smooth 
muscle contracting activity using the cascade 
superfusion technique [3 J. The assumption is that 
most known vasoactive agents are also smooth 
muscle contracting agents. The method makes use 
of the fact that different smooth muscle prepara-
tions have distinctive and specific sensitivities to 
different med iators. The responses of the series of 
isolated organ preparations chosen for inclusion in 
the cascade give a clue to the identity of the 
pharmacologic agents in the exudate and further 
information can then be gained by including spe-
cific pharmacologic antagonists in the superfusing 
solution. Confirmation of identity of mediators can 
finally be obtained by specific ex traction and 
identification procedures. 
Jr. after elimination of known mediators. resid-
ual pharmacologic acti\'ity remains. then this can 
be characterized physically and pharmacologically. 
It is not appropriate to elaborate here on the vari-
ous methods for extraction and identification which 
can be used for recognized mediators, but some 
general points are worth making. 
Bioa say is still the most satisfactory method for 
identification of pharmacologic mediators because 
it measures biologic activity. It can be highly 
sensitive. especially if combined with a physical 
separation procedure such as tbin-layer chroma-
tography. It can also be made highly specific by the 
parallel bioassay technique of Chang and Gaddum 
(4 J. Radioimmunoassay is becoming avai lable for 
assay of an increasing range of mediators. the 
advantage being that it enables rapid assay of a 
large num ber of samples. However it has the 
drawback that it measures immunoreactivit~, and 
not biologic activity, so it has to be validated by 
bioassay. 
Hist~mine is best determined by bioassay, and 
amount as litt le as 1 ng/ ml can be detected using 
the terminal guinea-pig ileum preparation. The 
practical difficulty arises if other smooth muscle 
contracting activity is present which cannot read-
ily be eliminated by extraction or by specific 
antagonists. The choice must then be between 
boiling in concentrated hydrochloric acid which 
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destroys all but histamine 15]. and f1uorometric as-
sa~· . Bradykinin can be identified b~' addition to rat 
uterus and duodenum preparations mounted in a 
single-organ bath. Bradykinin contracts the uterus 
but relaxes the duodenum. The assay should be 
carried out in the presence of phentolamine 
because a-adrenergic agents also relax the rat 
duodenum . Confirmation can be obtained by car-
rying out the assay in the presence of chymotrypsin 
which specifically enhances the response to brady-
kinin. Radioimmunoassay methods for bradykinin 
are still in a fairly early stage of development.. 
Serotonin is difficult to assay satisfactorily. 
Serotonin contracts the rat ute rus and its identity 
can be confi rmed by use of methysergide. a specific 
antagonist. Alternately it can be assayed fluoro-
metrically. Either way. it is difficult to detect less 
than 10 ng/ ml of se rotonin accurately. The deter-
mination of prostaglandin activity is a complex 
problem. Combined extraction. thin-layer chroma-
tography, and bioassay is probably a satisfactory 
method for most purposes. It is important to 
include indomethacin in t he superfusing solution 
to prevent endogenous prostaglandin synthesis in 
the contract ing isolated organ preparations. RadiO-
immunoassay of prostaglandin F 20 is well estab-
lished but the effectiveness of radioimmunoassay 
for other prostaglandin subclasses is less so. The 
ratio of prostaglandin E to prostaglandin F seems 
to be a key factor in an increasing number of 
physiologic and pathologic situations, so it is 
probably wise to choose a method which measures 
both. Combined gas chromatography and mass 
spectroscopy gives a comprehensive picture of all 
precursors and metabolites as well as of the prosta-
glandins themselves and it. can be made quantit.a-
tive. However. it is important to remember that it 
supplies no information about the biologic act ivi ty 
of the molecules it directs. 
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